Curi Bio

Curi Bio is a Seattle biotechnology company building human-relevant preclinical platforms for drug discovery. By combining human iPSC-derived cells, 3D engineered tissues, lab instruments, and AI/ML data analysis, it gives biopharma teams functional human data earlier in development - aiming to bridge the gap between animal/2D-cell models and the clinic across cardiac, skeletal muscle, metabolic, and neuromuscular diseases.